CIK 0001662579 · Non-accelerated filer<br>Smaller reporting company
C4 Therapeutics, Inc.
Sign in to watch- Ticker
- CCCC
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 475617627
- Phone
- (617) 231-0700
- Business address
- 490 ARSENAL WAY, SUITE 120, WATERTOWN, MA, 02472
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2023-04-03 | Anderson Kenneth Carl Director | Grant or award | +3,516 | $3.20 | $11K | 98,644 |
| 2023-04-03 | GROGAN DONNA ROY Director | Grant or award | +4,298 | $3.20 | $14K | 6,880 |
| 2023-02-15 | Hirsch Andrew President & CEO | Grant or award | +81,600 | 108,606 | ||
| 2023-02-15 | Hirsch Andrew President & CEO | Grant or award · Stock Option (Right to Buy) | +367,200 | 367,200 | ||
| 2023-02-13 | Fisher Stewart Chief Scientific Officer | Grant or award | +26,000 | 102,487 | ||
| 2023-02-13 | Fisher Stewart Chief Scientific Officer | Grant or award · Stock Option (Right to Buy) | +125,000 | 125,000 | ||
| 2023-02-13 | Siegel Jolie Chief Legal Officer | Grant or award | +20,000 | 25,097 | ||
| 2023-02-13 | Siegel Jolie Chief Legal Officer | Grant or award · Stock Option (Right to Buy) | +90,000 | 90,000 | ||
| 2023-02-13 | Boyle Scott N Chief Business Officer | Grant or award | +20,000 | 25,176 | ||
| 2023-02-13 | Boyle Scott N Chief Business Officer | Grant or award · Stock Option (Right to Buy) | +90,000 | 90,000 | ||
| 2023-02-13 | Schick Kelly Chief People Officer | Grant or award | +20,000 | 25,097 | ||
| 2023-02-13 | Schick Kelly Chief People Officer | Grant or award · Stock Option (Right to Buy) | +90,000 | 90,000 | ||
| 2023-02-13 | White Lauren Chief Financial Officer | Grant or award | +26,000 | 31,097 | ||
| 2023-02-13 | White Lauren Chief Financial Officer | Grant or award · Stock Option (Right to Buy) | +125,000 | 125,000 | ||
| 2023-02-08 | Koppikar Utpal Director | Purchase | +5,667 | $5.60 | $32K | 5,667 |
| 2023-01-30 | Crystal Adam Chief Medical Officer | Option exercise | +3,750 | 21,398 | ||
| 2023-01-30 | Crystal Adam Chief Medical Officer | Shares withheld for taxes | −1,301 | $7.78 | $10K | 20,097 |
| 2023-01-30 | Crystal Adam Chief Medical Officer | Option exercise · Performance Restricted Stock Units | −3,750 | 18,750 | ||
| 2023-01-30 | White Lauren Chief Financial Officer | Option exercise | +3,750 | 6,398 | ||
| 2023-01-30 | White Lauren Chief Financial Officer | Shares withheld for taxes | −1,301 | $7.78 | $10K | 5,097 |
Page 13 of 27 · 525 trades